Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can sensory training boost balance in down syndrome?

NCT ID NCT07785011

Disease control Sponsor: Raheel Sanad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial tests whether adding sensory integration therapy to a standard physical therapy program can improve balance and gross motor function in children with Down syndrome. Forty children aged 3 to 5 will be split into two groups: one receiving only physical therapy, and the other receiving physical therapy plus sensory integration activities like textured surfaces and vestibular stimulation. The study measures changes in balance and motor skills after three months of training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sensory integration therapy combined with a physical therapy program
What this could lead to
If effective, this approach could offer a new, non-drug way to improve balance and movement skills in young children with Down syndrome, potentially enhancing their independence and quality of life.
What could go wrong
This is a small, early-stage trial, so results may not apply to all children. The therapy's success depends on individual response, and there is a risk it may not produce significant improvements over standard physical therapy alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 5 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All children diagnosed as Down syndrome, according to genetic lab reports. * Their age ranges from 3to 5 years. * Both genders will be included. * They are able to stand alone. * They are able to follow instructions. Their IQ ranges from 65 to 80, according to Stanford Binet Intelligence Scale). * They had been referred by sensory integration problems (low registration and seeking behavior). Exclusion Criteria: Patients will be excluded from the study if they have any of the following: * Persistent heart disease. * Severe cognitive impairments. * Recent surgical interference in the lower limbs. * Obese children (BMI \> 95). * Patients with hip subluxation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Down syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Down syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Down syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Abo EL resh hospital

    RECRUITING

    Cairo, 02, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.